Advertisement

Advertisement

HK:9995 Stock Latest News

RemeGen Wins Fifth China Approval for Flagship ADC in Urothelial Cancer

Company AnnouncementsRemeGen Wins Fifth China Approval for Flagship ADC in Urothelial Cancer

RemeGen Wins NMPA Nod to Start Clinical Trial of Bispecific ADC RC288

PremiumCompany Announcements

RemeGen Wins NMPA Nod to Start Clinical Trial of Bispecific ADC RC288

11d ago

RemeGen Boosts 2025 Revenue as Telitacicept Wins New Approvals and NRDL Access

PremiumCompany Announcements

RemeGen Boosts 2025 Revenue as Telitacicept Wins New Approvals and NRDL Access

16d ago

RemeGen Wins Fourth NMPA Approval for Disitamab Vedotin in HER2-Low Breast Cancer

PremiumCompany Announcements

RemeGen Wins Fourth NMPA Approval for Disitamab Vedotin in HER2-Low Breast Cancer

20d ago

RemeGen Schedules March 27 Board Meeting to Approve 2025 Annual Results

PremiumCompany Announcements

RemeGen Schedules March 27 Board Meeting to Approve 2025 Annual Results

26d ago

RemeGen Swings to Profit on Strong 2025 Revenue Growth

PremiumCompany AnnouncementsRemeGen Swings to Profit on Strong 2025 Revenue Growth

1M ago

RemeGen Forecasts 2025 Profit Turnaround on Surging Drug Sales and Global Licensing Deal

Company Announcements

RemeGen Forecasts 2025 Profit Turnaround on Surging Drug Sales and Global Licensing Deal

2M ago

RemeGen Completes RMB20 Million A-Share Buyback for Future Equity Incentives

Company Announcements

RemeGen Completes RMB20 Million A-Share Buyback for Future Equity Incentives

3M ago

RemeGen Raises Share Buyback Price Cap to Enable A‑Share Repurchase Plan

PremiumCompany Announcements

RemeGen Raises Share Buyback Price Cap to Enable A‑Share Repurchase Plan

3M ago

RemeGen Signs Up to US$5.6 Billion Global Licensing Deal with AbbVie for Cancer Drug RC148

PremiumCompany Announcements

RemeGen Signs Up to US$5.6 Billion Global Licensing Deal with AbbVie for Cancer Drug RC148

3M ago

RemeGen Co., Ltd. Announces A Share Repurchase Plan to Boost Employee Incentives

PremiumCompany Announcements

RemeGen Co., Ltd. Announces A Share Repurchase Plan to Boost Employee Incentives

4M ago

RemeGen Co., Ltd. Approves Key Resolutions at 2025 EGM

PremiumCompany Announcements

RemeGen Co., Ltd. Approves Key Resolutions at 2025 EGM

4M ago

RemeGen Co., Ltd. Announces 2025 Third Extraordinary General Meeting

PremiumCompany AnnouncementsRemeGen Co., Ltd. Announces 2025 Third Extraordinary General Meeting

5M ago

RemeGen Co., Ltd. Engages in Strategic Wealth Management Transaction

Company Announcements

RemeGen Co., Ltd. Engages in Strategic Wealth Management Transaction

5M ago

RemeGen Co., Ltd. Releases 2025 Q3 Unaudited Financial Report

Company Announcements

RemeGen Co., Ltd. Releases 2025 Q3 Unaudited Financial Report

5M ago

RemeGen Co., Ltd. Renews Key Connected Transactions and Adjusts Leasing Agreements

PremiumCompany Announcements

RemeGen Co., Ltd. Renews Key Connected Transactions and Adjusts Leasing Agreements

5M ago

RemeGen Co., Ltd. Schedules Board Meeting to Review Q3 Results

PremiumCompany Announcements

RemeGen Co., Ltd. Schedules Board Meeting to Review Q3 Results

6M ago

RemeGen Co., Ltd. Engages in Strategic Cash Management with SPDB Wealth Products

PremiumCompany Announcements

RemeGen Co., Ltd. Engages in Strategic Cash Management with SPDB Wealth Products

6M ago

RemeGen Co., Ltd. Engages in Wealth Management Product Purchase

PremiumCompany Announcements

RemeGen Co., Ltd. Engages in Wealth Management Product Purchase

8M ago

RemeGen’s Telitacicept Achieves Key Milestone in IgA Nephropathy Trial

PremiumCompany AnnouncementsRemeGen’s Telitacicept Achieves Key Milestone in IgA Nephropathy Trial

8M ago

RemeGen Co., Ltd. Updates Articles of Association Following Share Placement

Company Announcements

RemeGen Co., Ltd. Updates Articles of Association Following Share Placement

8M ago

RemeGen Co., Ltd. Reports Strong Revenue Growth and Key Product Approvals in 2025

Company Announcements

RemeGen Co., Ltd. Reports Strong Revenue Growth and Key Product Approvals in 2025

8M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >